Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can art and therapy tame Treatment-Resistant psychosis?

NCT ID NCT07183982

Disease control Sponsor: Oman Ministry of Health Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested a 6-month rehabilitation program for people with treatment-resistant psychosis in a forensic psychiatric hospital. The program included psychodynamic therapy, music and art therapy, and cognitive exercises. Twenty patients were split into two groups to compare the new program with standard rehab. The goal was to see if symptoms and thinking skills improved.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Multidisciplinary rehabilitation program (psychodynamic group therapy, music and art therapy, cognitive stimulation)
What this could lead to
If it works, this could point toward a better way to manage symptoms and improve daily function for people with hard-to-treat psychosis in forensic settings.
What could go wrong
This is a very small study (20 people) with no blinding or randomization, so results may not be reliable or apply to others. The program is intensive and may not be feasible everywhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Jul 2025

Finished

Aug 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Diagnosis of chronic psychotic disorder (e.g., schizophrenia or schizoaffective disorder) confirmed by psychiatric assessment and medical records. 2. Presence of residual psychotic symptoms (positive symptoms such as hallucinations, delusions; and/or negative symptoms such as blunted affect, social withdrawal) despite ongoing psychotropic treatment. 3. Medically stable and deemed suitable for participation by the treating psychiatrist or healthcare team. 4. Patients who provide informed consent to participate in the rehabilitation program and research study. Exclusion Criteria: 1. Acute medical or psychiatric conditions requiring immediate intervention. 2. Developmental or intellectual disabilities that significantly impair participation in the rehabilitation program or assessments. 3. Current substance dependence that would interfere with participation. 4. Significant risk of harm to self or others, based on clinical assessment or history of violence/aggression. 5. Contraindications to specific rehabilitation program components (e.g., physical exercise, group activities) as determined by medical evaluation. 6. Inability to comprehend study requirements or provide informed consent due to language barriers, cognitive impairment, or other factors.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Forensic psychiatric patients are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

schizoaffective disorder schizophrenia treatment-refractory schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Forensic psychiatric patients Schizophenia disorder

Contacts and locations

Locations

  • Al Massara Hospital

    Muscat, Muḩāfaz̧at Masqaţ, Oman

More trials for these conditions

Other studies related to the condition(s) this trial covers.